Healthcare provider profile · identity verified

Nathan Matthews, D.O.

Family Practice · MESA, AZ · NPI 1720307176

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	467	123
Atorvastatin Calcium	Atorvastatin Calcium	463	138
Pantoprazole Sodium	Pantoprazole Sodium	314	93
Lisinopril	Lisinopril	307	89
Losartan Potassium	Losartan Potassium	307	86
Rosuvastatin Calcium	Rosuvastatin Calcium	253	71
Amlodipine Besylate	Amlodipine Besylate	240	73
Metformin Hcl	Metformin Hcl	229	65
Tamsulosin Hcl	Tamsulosin Hcl	222	61
Gabapentin	Gabapentin	187	59
Simvastatin	Simvastatin	152	44
Montelukast Sodium	Montelukast Sodium	151	47
Meloxicam	Meloxicam	149	40
Omeprazole	Omeprazole	130	39
Hydrochlorothiazide	Hydrochlorothiazide	127	44
Albuterol Sulfate Hfa	Albuterol Sulfate	124	43
Metoprolol Succinate	Metoprolol Succinate	123	42
Pravastatin Sodium	Pravastatin Sodium	123	36
Allopurinol	Allopurinol	113	31
Escitalopram Oxalate	Escitalopram Oxalate	107	29
Trazodone Hcl	Trazodone Hcl	103	25
Sertraline Hcl	Sertraline Hcl	102	25
Tramadol Hcl	Tramadol Hcl	96	32
Furosemide	Furosemide	91	34
Zolpidem Tartrate	Zolpidem Tartrate	88	20
Celecoxib	Celecoxib	83	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	83	22
Eliquis	Apixaban	78	16
Citalopram Hbr	Citalopram Hydrobromide	77	18
Metformin Hcl Er	Metformin Hcl	77	23
Ozempic	Semaglutide	76	12
Diazepam	Diazepam	70	15
Methylprednisolone	Methylprednisolone	70	62
Oxycodone Hcl	Oxycodone Hcl	68	13
Atenolol	Atenolol	66	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	19
Xarelto	Rivaroxaban	65	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	64	19
Alprazolam	Alprazolam	63	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	16
Diclofenac Sodium	Diclofenac Sodium	61	23
Quetiapine Fumarate	Quetiapine Fumarate	61	16
Alendronate Sodium	Alendronate Sodium	59	18
Duloxetine Hcl	Duloxetine Hcl	59	17
Fluoxetine Hcl	Fluoxetine Hcl	59	16
Baclofen	Baclofen	58	27
Glimepiride	Glimepiride	55	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	14
Carvedilol	Carvedilol	53	14
Valacyclovir	Valacyclovir Hcl	53	18
Pregabalin	Pregabalin	52	suppressed
Prednisone	Prednisone	51	37
Valsartan	Valsartan	48	13
Acyclovir	Acyclovir	47	13
Fluticasone Propionate	Fluticasone Propionate	47	22
Januvia	Sitagliptin Phosphate	47	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	38
Clopidogrel	Clopidogrel Bisulfate	45	15
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Bupropion Xl	Bupropion Hcl	42	14
Benazepril Hcl	Benazepril Hcl	41	13
Metoprolol Tartrate	Metoprolol Tartrate	41	15
Mirtazapine	Mirtazapine	40	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	16
Tizanidine Hcl	Tizanidine Hcl	39	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	12
Spironolactone	Spironolactone	38	11
Azithromycin	Azithromycin	37	35
Glipizide Er	Glipizide	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	11
Finasteride	Finasteride	36	13
Warfarin Sodium	Warfarin Sodium	36	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	34	suppressed
Famotidine	Famotidine	33	suppressed
Methocarbamol	Methocarbamol	33	12
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	suppressed
Ibuprofen	Ibuprofen	32	14
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Potassium Chloride	Potassium Chloride	31	14
Primidone	Primidone	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	30	26
Estradiol	Estradiol	30	11
Ezetimibe	Ezetimibe	30	suppressed
Lorazepam	Lorazepam	30	11
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	11
Cephalexin	Cephalexin	27	19
Jardiance	Empagliflozin	26	suppressed
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Ondansetron Odt	Ondansetron	24	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Cefdinir	Cefdinir	23	22
Fluconazole	Fluconazole	23	19
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Temazepam	Temazepam	23	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	11
Synthroid	Levothyroxine Sodium	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Donepezil Hcl	Donepezil Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Bumetanide	Bumetanide	17	suppressed
Colchicine	Colchicine	17	suppressed
Levofloxacin	Levofloxacin	17	15
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Testosterone	Testosterone	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Armour Thyroid	Thyroid,pork	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Naproxen	Naproxen	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error